Taima Growth

www.taimagrowth.com ↗ ·Pardilla ·Other

Taima Growth is a Burgos-based company that grows pharmaceutical-grade medical cannabis indoors for the pharmaceutical industry. It is one of four companies licensed by Spain's medicines agency (AEMPS) to cultivate medical cannabis. Its indoor facility in the Ribera del Duero area of Burgos uses controlled-environment, rock wool-based growing to GACP and GMP standards, with 3-5 harvests a year. It targets an initial output of about 1,250 kg a year, rising to as much as nine tonnes, and plans to sell mainly to the UK and German markets. Founder and CEO Mo Alyasini started the project in November 2019. More than €3 million has been invested, all from Spanish investors, including the partners of Aurea Capital Partners. Kanabo Agritec, a subsidiary of Kanabo Group, holds an equity stake linked to the consulting services it provided for the facility.

Founded

2019

Founders

Total funds raised

—

SectorsMedical cannabis, Pharmaceuticals, Controlled-environment agriculture Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Mo Alyasini

Founder & CEO

Global models 3

Tilray

Canada · www.tilray.com ↗

Before its IPO it was backed by Privateer Holdings (Founders Fund) and grew GMP-certified pharmaceutical-grade medical cannabis indoors, selling it to pharma and medical channels in Germany, the UK and other EU markets.

$100M+Comparable

Clever Leaves

Colombia · cleverleaves.com ↗

A venture-funded licensed cultivator that grows EU-GMP pharmaceutical-grade cannabis and sells it wholesale to pharma and medical distributors in Germany, the UK and other export markets.

$100MComparable

Demecan

Germany · www.demecan.de ↗

One of a handful of cultivators licensed by a national medicines regulator (Germany's BfArM) to grow pharmaceutical-grade medical cannabis indoors under GMP and supply it to the pharma supply chain.

$30MComparable